Health Canada drug identification number

DIN 02486296 — TRI-JORDYNA 21 0.035 MG; 0.035 MG; 0.035 MG; 0.18 MG; 0.215 MG; 0.25 MG

TRI-JORDYNA 21 is a tablet of Ethinyl Estradiol / Norgestimate marketed by GLENMARK PHARMACEUTICALS CANADA INC.. The full Ethinyl Estradiol / Norgestimate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02486296
Brand name
TRI-JORDYNA 21
Strength
0.035 MG; 0.035 MG; 0.035 MG; 0.18 MG; 0.215 MG; 0.25 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
GLENMARK PHARMACEUTICALS CANADA INC.
Health Canada status
MARKETED
Drug class
Estrogen-progestin combination (combined oral contraceptive, triphasic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ethinyl Estradiol / Norgestimate products

DINBrandStrengthFormManufacturerStatus
02508087 TRI-CIRA 21 0.25 MG; 0.035 MG; 0.18 MG; 0.035 MG; 0.035 MG; 0.215 MG TABLET APOTEX INC MARKETED
02508095 TRI-CIRA 28 0.215 MG; 0.25 MG; 0.18 MG; 0.035 MG; 0.035 MG; 0.035 MG TABLET APOTEX INC MARKETED
02401967 TRI-CIRA LO 21 0.025 MG; 0.025 MG; 0.215 MG; 0.25 MG; 0.025 MG; 0.18 MG TABLET APOTEX INC MARKETED
02401975 TRI-CIRA LO 28 0.025 MG; 0.025 MG; 0.215 MG; 0.25 MG; 0.025 MG; 0.18 MG TABLET APOTEX INC MARKETED
02486318 TRI-JORDYNA 28 0.18 MG; 0.035 MG; 0.035 MG; 0.035 MG; 0.25 MG; 0.215 MG TABLET GLENMARK PHARMACEUTICALS CANADA INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.